Evidence map›Paper›PMID 41365948›Full record

ArticleScientific reports2025

Hypergraph clustering for analyzing chronic disease patterns in mild cognitive impairment reversion and progression.

Muskan Garg, Xingyi Liu, Eunji Jeon, Maria Vassilaki, Ronald C Petersen, Jennifer St Sauver, Sunghwan Sohn

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Muskan GargDepartment of Artificial Intelligence & Informatics, Mayo Clinic, Rochester, MN, USA.
Xingyi LiuDepartment of Artificial Intelligence & Informatics, Mayo Clinic, Rochester, MN, USA.
Eunji JeonDepartment of Artificial Intelligence & Informatics, Mayo Clinic, Rochester, MN, USA.
Maria VassilakiDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Ronald C PetersenDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Jennifer St SauverDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Sunghwan SohnDepartment of Artificial Intelligence & Informatics, Mayo Clinic, Rochester, MN, USA. sohn.sunghwan@mayo.edu.

Funding

SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
Research Education ComponentP30AG062677 · NIA · MAYO CLINIC ROCHESTER · PI Pamela J McLean · 2019 to 2026
$33.5M
Disease pathways in the population determined by amyloid, tau, and neurodegeneration imaging biomarkersR37AG011378 · NIA · MAYO CLINIC ROCHESTER · PI CLIFFORD R. JACK · 2018 to 2026
$6.8M
Validating the New Criteria for Preclinical Alzheimer's diseaseR01AG041851 · NIA · MAYO CLINIC ROCHESTER · PI JACK, CLIFFORD R., KNOPMAN, DAVID S · 2012 to 2021
$6.3M
Early Detection of Mild Cognitive Impairment, Alzheimer’s Disease and Other Dementias using EHRR01AG068007 · NIA · MAYO CLINIC ROCHESTER · PI Yonas E Geda, Sunghwan Sohn · 2020 to 2026
$3.8M
Advancing women’s care in Alzheimer’s disease and other dementias through EHRRF1AG090341 · NIA · MAYO CLINIC ROCHESTER · PI SOHN, SUNGHWAN · 2025 to 2025
$3.4M
Development, Validation, and Application of an Imaging based CVD ScaleR01NS097495 · NINDS · MAYO CLINIC ROCHESTER · PI VEMURI, PRASHANTHI · 2016 to 2020
$2.9M
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology ProjectR33AG058738 · NIA · MAYO CLINIC ROCHESTER · PI LEBRASSEUR, NATHAN K, OLSON, JANET E · 2020 to 2022
$2.4M
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology ProjectR21AG058738 · NIA · MAYO CLINIC ROCHESTER · PI LEBRASSEUR, NATHAN K, OLSON, JANET E · 2018 to 2019
$437k
NIA NIH HHS P30 AG062677NIA NIH HHS R01 AG041851NIA NIH HHS R01 AG068007NIA NIH HHS R21 AG058738NIA NIH HHS R33 AG058738NIA NIH HHS R37 AG011378NIA NIH HHS RF1 AG090341NIA NIH HHS U01 AG006786NIH HHS R01 AG068007 and RF1 AG090341NINDS NIH HHS R01 NS097495
6 · The paper itself

Abstract

Identifying the sequential patterns of chronic conditions that precede the onset of mild cognitive impairment (MCI) is essential for understanding both the progression and the potential reversal of MCI. This study identifies common sequences of chronic conditions preceding MCI and introduces a novel, network-based clustering framework for characterizing patients with similar progression patterns linked to cognitive trajectories. We used the Mayo Clinic Study of Aging (MCSA) cohort and categorized participants of MCSA into two groups (i) stay at MCI or progressed to dementia, or (ii) reversion to normal within 5 years after the first onset of MCI. We curate the state transition network (patient level) for identifying and introduced hypergraph clustering (patient group level) to characterize participants with similar sequences. We identified generic key indicators (e.g., chronic kidney disease) and highlighted sex-specific potential indicators (e.g., arthritis, hypertension) associated with MCI reversal, opening new research directions to explore potential differences between males and females. There are certain ssequences of chronic conditions (e.g., originating from arthritis) that are more commonly observed in females. However, these observations warrant further validation. The proposed framework - hypergraph clustering - offers a promising method for uncovering similarities in patients through unique trajectories of chronic conditions that precede MCI.

Indexed as

Cognitive DysfunctionAgedAged, 80 and overChronic DiseaseCluster AnalysisDisease ProgressionFemaleHumansMaleChronic conditionsDementiaDisease trajectoriesHypergraph clusteringMild cognitive impairmentMild cognitive impairment reversion

Identifiers

PMID41365948
PMCPMC12689848

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.